Invention Grant
- Patent Title: Protein and lipid biomarkers providing consistent improvement to the prediction of Type 2 diabetes
-
Application No.: US14945200Application Date: 2015-11-18
-
Publication No.: US09810697B2Publication Date: 2017-11-07
- Inventor: Michael P. McKenna , Steve M. Watkins
- Applicant: True Health Diagnostics, LLC
- Applicant Address: US TX Frisco
- Assignee: True Health IP, LLC
- Current Assignee: True Health IP, LLC
- Current Assignee Address: US TX Frisco
- Agency: Perkins Coie LLP
- Main IPC: G01N31/00
- IPC: G01N31/00 ; G01N33/53 ; G01N33/68 ; G01N33/66 ; G01N33/92 ; G06F19/00

Abstract:
The invention relates to biomarkers associated with Diabetes, including protein and lipid metabolite biomarkers, methods of using the biomarkers to determine the risk that an individual will develop Diabetes, and methods of screening a population to identify persons at risk for developing Diabetes and other pre-diabetic conditions.
Public/Granted literature
- US20170003297A1 PROTEIN AND LIPID BIOMARKERS PROVIDING CONSISTENT IMPROVEMENT TO THE PREDICTION OF TYPE 2 DIABETES Public/Granted day:2017-01-05
Information query